BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4637534)

  • 21. Osteodystrophy in patients with chronic renal failure.
    Fearing MO
    Nurs Clin North Am; 1975 Sep; 10(3):461-8. PubMed ID: 1041628
    [No Abstract]   [Full Text] [Related]  

  • 22. [Bone changes induced by hormones in renal osteopathy. Studies on the macro- and microstructure of bones].
    von Babo H; Heuck F
    Radiologe; 1974 May; 14(5):225-31. PubMed ID: 4603368
    [No Abstract]   [Full Text] [Related]  

  • 23. Parathyroid dysfunction end stage renal disease.
    DiTella PJ; Lang GR
    Otolaryngol Clin North Am; 1980 Feb; 13(1):193-201. PubMed ID: 7367004
    [No Abstract]   [Full Text] [Related]  

  • 24. Hepatic metabolism of vitamin D in chronic renal failure.
    Farrington K; Skinner RK; Varghese Z; Moorhead JF
    Lancet; 1979 Feb; 1(8111):321. PubMed ID: 84969
    [No Abstract]   [Full Text] [Related]  

  • 25. What is the role of bone biopsy in the management of adult dialysis patients?
    El-Husseini A; Sawaya BP
    Semin Dial; 2014; 27(3):266-9. PubMed ID: 24684712
    [No Abstract]   [Full Text] [Related]  

  • 26. [Chronic renal failure: present and future. Pathophysiology and metabolic abnormalities--Recent advances of therapeutic approach toward renal osteodystrophy].
    Ogura Y; Kawaguchi Y
    Nihon Naika Gakkai Zasshi; 1986 Nov; 75(11):1555-8. PubMed ID: 3819558
    [No Abstract]   [Full Text] [Related]  

  • 27. Current status of the management of renal osteodystrophy.
    Fournier A; Sebert JL; Coevoet B; De Fremont JF; Hardin JM; Lambrey G
    Proc Eur Dial Transplant Assoc; 1978; 15():547-68. PubMed ID: 368790
    [No Abstract]   [Full Text] [Related]  

  • 28. [Renal osteodystrophy--more than a mere bone disease].
    Saha H
    Duodecim; 2001; 117(21):2181-7. PubMed ID: 12184205
    [No Abstract]   [Full Text] [Related]  

  • 29. [Role of aluminium and magnesium effects on initiation and promotion of renal osteodystrophy in patients with chronic renal failure].
    Nakamrua M; Sato N; Tsukamoto Y; Marumo F; Iwanami S
    Nihon Jinzo Gakkai Shi; 1986 Apr; 28(4):421-8. PubMed ID: 3747253
    [No Abstract]   [Full Text] [Related]  

  • 30. Skeletal complications of kidney disease.
    Crutchlow WP; David DS
    Clin Orthop Relat Res; 1971 Jan; 74():209-20. PubMed ID: 4924794
    [No Abstract]   [Full Text] [Related]  

  • 31. [Skeletal and soft part changes in patients on chronic dialysis].
    Herrmann K; Krohs G
    Z Gesamte Inn Med; 1974 Nov; 29(21):891-5. PubMed ID: 4462343
    [No Abstract]   [Full Text] [Related]  

  • 32. [Calcitonin for therapy of renal osteodystrophy due to long-term hemodialysis in patients with chronic kidney failure].
    Ishida M; Yamada M
    Nihon Rinsho; 1991 Dec; 49 Suppl():725-31. PubMed ID: 1808343
    [No Abstract]   [Full Text] [Related]  

  • 33. [Bone metabolism markers and bone histomorphometry in children with chronic renal failure in predialysis period during growth hormone treatment].
    Pańczyk-Tomaszewska M; Ziółkowska H; Debiński A; Sawicki A; Zurowska A; Pietrzyk JA; Roszkowska-Blaim M
    Pol Merkur Lekarski; 2000 Apr; 8(46):264-5. PubMed ID: 10897642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Metabolic changes in bones and modification of growth in children with chronic renal failure, dialyzed and with kidney transplant].
    Wigger M; Gellert S; Grossmann P; Stolpe HJ
    Z Urol Nephrol; 1988 Jan; 81(1):19-25. PubMed ID: 3284240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of metacarpal and iliac bone in chronic renal failure: influence of haemodialysis, parathyroid activity, type of renal disease, physical activity and heparin consumption.
    Henderson RG; Russell RG; Earnshaw MJ; Ledingham JG; Oliver DO; Woods CG
    Clin Sci (Lond); 1979 Apr; 56(4):317-24. PubMed ID: 477216
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical study on the disturbances in calcium and bone disease: renal osteodystrophy in patients with chronic renal failure].
    Yoshidome E
    Igaku Kenkyu; 1987 May; 57(2):83-104. PubMed ID: 3673482
    [No Abstract]   [Full Text] [Related]  

  • 37. Renal osteodystrophy.
    Bardin T
    Rev Rhum Engl Ed; 1997 Jun; 64(6 Suppl):114S-118S. PubMed ID: 9273952
    [No Abstract]   [Full Text] [Related]  

  • 38. [Use of 5,6-trans-25-OH-cholecalciferol in patients needing dialysis with florid renal osteopathy: therapeutic management and treatment results].
    Cremer W; Graben N; Merguet P
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1307-10. PubMed ID: 611841
    [No Abstract]   [Full Text] [Related]  

  • 39. [The effects of CaCO3 on renal osteodystrophy--comparison of patients with chronic renal failure in the predialytic stage and patients undergoing maintenance hemodialysis].
    Okada K; Kuno T; Yanai M; Maeda H; Takahashi S; Hatano M
    Nihon Jinzo Gakkai Shi; 1988 Aug; 30(8):1053-62. PubMed ID: 3244188
    [No Abstract]   [Full Text] [Related]  

  • 40. [Complications suffered by dialysis patients. 3. Ca and P metabolism disorders of bone].
    Suzuki M
    Nihon Naika Gakkai Zasshi; 2000 Jul; 89(7):1358-65. PubMed ID: 11032503
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.